Just wait, some POS will write another hate piece and then MF will jump on and BP will pay up...we need an advocate in a powerful place .
Is NVIV traveling in a different time-space continuum along with other bio's I hold like AVXL, RGIN, MSTX to name a few. I think they each have potential but have not moved much in recent months. Is it a Bio thing?
Isn't that basically what BP has been doing for 30 years(kicking the can), with a few notable exceptions.
" I am in no hurry...."...I am...the sooner we get action/PR/partnership/Rett/PD/AD/anxiety disorder treatment...results/study/trials/whatever...TH BETTER
"Markets interpreted this one-point decline as indicative of inefficacy, but we believe that this is not the case. This study is subject to statistical variance, given its objective limitations, and the single point decline across the more than 30-week period could easily come about as a result of this variance. Further, in a host of secondary endpoints, the drug performed exceptionally. It translated to a 29% improvement in insomnia, a 21% improvement in work and activity ability, and an 18% improvement in anxiety related issues. It also improved working memory and attention.
We are not saying it is a holy grail Alzheimer’s cure, but based on this small sample size of data, we don’t see any reason for a 45% decline in market capitalization. Yes, it is a bit disappointing that MMSE scores didn’t improve, but in a condition like this, stability is a big win."
Obvious bias in choice of terms and in structure-emphasis-sequence of events. Beyond annoying.
"not much", suppose it is a matter of buyers discretion in some context. I would agree that you have to WANT to own it.